 | • レポートコード：20QY06-01584 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、グアイフェネシン（API）のグローバル市場について種類別（98%-99%、>99%）、用途別（医薬品、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・グアイフェネシン（API）市場の概要 ・世界の主要地域別グアイフェネシン（API）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のグアイフェネシン（API）市場規模2015-2026：種類別（98%-99%、>99%） ・世界のグアイフェネシン（API）市場規模2015-2026：用途別（医薬品、その他） ・グアイフェネシン（API）の北米市場規模2015-2020 ・グアイフェネシン（API）のヨーロッパ市場規模2015-2020 ・グアイフェネシン（API）の中国市場規模2015-2020 ・グアイフェネシン（API）の日本市場規模2015-2020 ・グアイフェネシン（API）の東南アジア市場規模2015-2020 ・グアイフェネシン（API）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Granules、Synthokem Labs、Haizhou Pharma、Yuan Cheng Group、Stellar Chemical、Biesterfeld、Seven Star Pharma、Camlin Fine Science、Gennex Lab、Iwaki Seiyaku、Pan Drugs、Delta Synthetic、Smart Pharm） ・グアイフェネシン（API）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・グアイフェネシン（API）の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Guaifenesin (API) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Guaifenesin (API) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Guaifenesin (API) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Guaifenesin (API) industry.
Based on our recent survey, we have several different scenarios about the Guaifenesin (API) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 56 million in 2019. The market size of Guaifenesin (API) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Guaifenesin (API) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Guaifenesin (API) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Guaifenesin (API) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Guaifenesin (API) market. The report also includes nautical information, where it shows Guaifenesin (API) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Guaifenesin (API) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Guaifenesin (API) market.
The global average price of Guaifenesin (API) is in the decreasing trend, from 8.62 USD/Kg in 2012 to 7.61 USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
Geographical Analysis:
Based on region, the global Guaifenesin (API) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Guaifenesin (API) market are
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Segment by Type
98%-99%
>99%
Segment by Application
Pharmaceuticals
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Guaifenesin (API) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Guaifenesin (API) market.
• The market share of the global Guaifenesin (API) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Guaifenesin (API) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Guaifenesin (API) market.
1 Guaifenesin (API) Market Overview
1.1 Guaifenesin (API) Product Scope
1.2 Guaifenesin (API) Segment by Type
1.2.1 Global Guaifenesin (API) Sales by Type (2020-2026)
1.2.2 98%-99%
1.2.3 >99%
1.3 Guaifenesin (API) Segment by Application
1.3.1 Global Guaifenesin (API) Sales Comparison by Application (2020-2026)
1.3.2 Pharmaceuticals
1.3.3 Others
1.4 Guaifenesin (API) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Guaifenesin (API) Sales Growth Rate (2015-2026)
1.4.2 Global Guaifenesin (API) Revenue and Growth Rate (2015-2026)
1.4.3 Global Guaifenesin (API) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Guaifenesin (API) Industry Impact
1.5.1 How the Covid-19 is Affecting the Guaifenesin (API) Industry
1.5.1.1 Guaifenesin (API) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Guaifenesin (API) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Guaifenesin (API) Players to Combat Covid-19 Impact
2 Guaifenesin (API) Estimate and Forecast by Region
2.1 Global Guaifenesin (API) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Guaifenesin (API) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Guaifenesin (API) Sales Market Share by Region (2015-2020)
2.2.2 Global Guaifenesin (API) Revenue Market Share by Region (2015-2020)
2.3 Global Guaifenesin (API) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Guaifenesin (API) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Guaifenesin (API) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Guaifenesin (API) Estimates and Projections (2015-2026)
2.4.2 Europe Guaifenesin (API) Estimates and Projections (2015-2026)
2.4.3 China Guaifenesin (API) Estimates and Projections (2015-2026)
2.4.4 Japan Guaifenesin (API) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Guaifenesin (API) Estimates and Projections (2015-2026)
2.4.6 India Guaifenesin (API) Estimates and Projections (2015-2026)
3 Global Guaifenesin (API) Competition Landscape by Players
3.1 Global Top Guaifenesin (API) Players by Sales (2015-2020)
3.2 Global Top Guaifenesin (API) Players by Revenue (2015-2020)
3.3 Global Guaifenesin (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guaifenesin (API) as of 2019)
3.4 Global Guaifenesin (API) Average Price by Company (2015-2020)
3.5 Manufacturers Guaifenesin (API) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Guaifenesin (API) Players (Opinion Leaders)
4 Global Guaifenesin (API) Market Size by Type
4.1 Global Guaifenesin (API) Historic Market Review by Type (2015-2020)
4.1.1 Global Guaifenesin (API) Sales Market Share by Type (2015-2020)
4.1.2 Global Guaifenesin (API) Revenue Market Share by Type (2015-2020)
4.1.3 Global Guaifenesin (API) Price by Type (2014-2020)
4.2 Global Guaifenesin (API) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Guaifenesin (API) Sales Forecast by Type (2021-2026)
4.2.2 Global Guaifenesin (API) Revenue Forecast by Type (2021-2026)
4.2.3 Global Guaifenesin (API) Price Forecast by Type (2021-2026)
5 Global Guaifenesin (API) Market Size by Application
5.1 Global Guaifenesin (API) Historic Market Review by Application (2015-2020)
5.1.1 Global Guaifenesin (API) Sales Market Share by Application (2015-2020)
5.1.2 Global Guaifenesin (API) Revenue Market Share by Application (2015-2020)
5.1.3 Global Guaifenesin (API) Price by Application (2015-2020)
5.2 Global Guaifenesin (API) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Guaifenesin (API) Sales Forecast by Application (2021-2026)
5.2.2 Global Guaifenesin (API) Revenue Forecast by Application (2021-2026)
5.2.3 Global Guaifenesin (API) Price Forecast by Application (2021-2026)
3 North America Guaifenesin (API) Market Facts & Figures
3.2 North America Guaifenesin (API) Sales Market Share by Company (2015-2020)
3.3 North America Guaifenesin (API) Sales Market Share by Type (2015-2020)
3.4 North America Guaifenesin (API) Sales Market Share by Application (2015-2020)
4 Europe Guaifenesin (API) Market Facts & Figures
4.2 Europe Guaifenesin (API) Sales Market Share by Company (2015-2020)
4.3 Europe Guaifenesin (API) Sales Market Share by Type (2015-2020)
4.4 Europe Guaifenesin (API) Sales Market Share by Application (2015-2020)
5 China Guaifenesin (API) Market Facts & Figures
5.2 China Guaifenesin (API) Sales Market Share by Company (2015-2020)
5.3 China Guaifenesin (API) Sales Market Share by Type (2015-2020)
5.4 China Guaifenesin (API) Sales Market Share by Application (2015-2020)
6 Japan Guaifenesin (API) Market Facts & Figures
6.2 Japan Guaifenesin (API) Sales Market Share by Company (2015-2020)
6.3 Japan Guaifenesin (API) Sales Market Share by Type (2015-2020)
6.4 Japan Guaifenesin (API) Sales Market Share by Application (2015-2020)
7 Southeast Asia Guaifenesin (API) Market Facts & Figures
7.2 Southeast Asia Guaifenesin (API) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Guaifenesin (API) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Guaifenesin (API) Sales Market Share by Application (2015-2020)
8 India Guaifenesin (API) Market Facts & Figures
8.2 India Guaifenesin (API) Sales Market Share by Company (2015-2020)
8.3 India Guaifenesin (API) Sales Market Share by Type (2015-2020)
8.4 India Guaifenesin (API) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Guaifenesin (API) Business
12.1 Granules
12.1.1 Granules Guaifenesin (API) Corporation Information
12.1.2 Granules Guaifenesin (API) Business Overview and Total Revenue
12.1.3 Granules Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Granules Guaifenesin (API) Products Offered
12.1.5 Granules Recent Development
12.2 Synthokem Labs
12.2.1 Synthokem Labs Guaifenesin (API) Corporation Information
12.2.2 Synthokem Labs Guaifenesin (API) Business Overview and Total Revenue
12.2.3 Synthokem Labs Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Synthokem Labs Guaifenesin (API) Products Offered
12.2.5 Synthokem Labs Recent Development
12.3 Haizhou Pharma
12.3.1 Haizhou Pharma Guaifenesin (API) Corporation Information
12.3.2 Haizhou Pharma Guaifenesin (API) Business Overview and Total Revenue
12.3.3 Haizhou Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Haizhou Pharma Guaifenesin (API) Products Offered
12.3.5 Haizhou Pharma Recent Development
12.4 Yuan Cheng Group
12.4.1 Yuan Cheng Group Guaifenesin (API) Corporation Information
12.4.2 Yuan Cheng Group Guaifenesin (API) Business Overview and Total Revenue
12.4.3 Yuan Cheng Group Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Yuan Cheng Group Guaifenesin (API) Products Offered
12.4.5 Yuan Cheng Group Recent Development
12.5 Stellar Chemical
12.5.1 Stellar Chemical Guaifenesin (API) Corporation Information
12.5.2 Stellar Chemical Guaifenesin (API) Business Overview and Total Revenue
12.5.3 Stellar Chemical Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Stellar Chemical Guaifenesin (API) Products Offered
12.5.5 Stellar Chemical Recent Development
12.6 Biesterfeld
12.6.1 Biesterfeld Guaifenesin (API) Corporation Information
12.6.2 Biesterfeld Guaifenesin (API) Business Overview and Total Revenue
12.6.3 Biesterfeld Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Biesterfeld Guaifenesin (API) Products Offered
12.6.5 Biesterfeld Recent Development
12.7 Seven Star Pharma
12.7.1 Seven Star Pharma Guaifenesin (API) Corporation Information
12.7.2 Seven Star Pharma Guaifenesin (API) Business Overview and Total Revenue
12.7.3 Seven Star Pharma Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Seven Star Pharma Guaifenesin (API) Products Offered
12.7.5 Seven Star Pharma Recent Development
12.8 Camlin Fine Science
12.8.1 Camlin Fine Science Guaifenesin (API) Corporation Information
12.8.2 Camlin Fine Science Guaifenesin (API) Business Overview and Total Revenue
12.8.3 Camlin Fine Science Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Camlin Fine Science Guaifenesin (API) Products Offered
12.8.5 Camlin Fine Science Recent Development
12.9 Gennex Lab
12.9.1 Gennex Lab Guaifenesin (API) Corporation Information
12.9.2 Gennex Lab Guaifenesin (API) Business Overview and Total Revenue
12.9.3 Gennex Lab Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Gennex Lab Guaifenesin (API) Products Offered
12.9.5 Gennex Lab Recent Development
12.10 Iwaki Seiyaku
12.10.1 Iwaki Seiyaku Guaifenesin (API) Corporation Information
12.10.2 Iwaki Seiyaku Guaifenesin (API) Business Overview and Total Revenue
12.10.3 Iwaki Seiyaku Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Iwaki Seiyaku Guaifenesin (API) Products Offered
12.10.5 Iwaki Seiyaku Recent Development
12.11 Pan Drugs
12.11.1 Pan Drugs Guaifenesin (API) Corporation Information
12.11.2 Pan Drugs Guaifenesin (API) Business Overview and Total Revenue
12.11.3 Pan Drugs Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pan Drugs Guaifenesin (API) Products Offered
12.11.5 Pan Drugs Recent Development
12.12 Delta Synthetic
12.12.1 Delta Synthetic Guaifenesin (API) Corporation Information
12.12.2 Delta Synthetic Guaifenesin (API) Business Overview and Total Revenue
12.12.3 Delta Synthetic Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Delta Synthetic Guaifenesin (API) Products Offered
12.12.5 Delta Synthetic Recent Development
12.13 Smart Pharm
12.13.1 Smart Pharm Guaifenesin (API) Corporation Information
12.13.2 Smart Pharm Guaifenesin (API) Business Overview and Total Revenue
12.13.3 Smart Pharm Guaifenesin (API) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Smart Pharm Guaifenesin (API) Products Offered
12.13.5 Smart Pharm Recent Development
13 Guaifenesin (API) Manufacturing Cost Analysis
13.1 Guaifenesin (API) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Guaifenesin (API)
13.4 Guaifenesin (API) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Guaifenesin (API) Distributors List
14.3 Guaifenesin (API) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Guaifenesin (API) Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Guaifenesin (API) Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Guaifenesin (API) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Guaifenesin (API) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Guaifenesin (API) Players to Combat Covid-19 Impact
Table 8. Global Market Guaifenesin (API) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Guaifenesin (API) Sales (MT) by Region (2015-2020)
Table 10. Global Guaifenesin (API) Sales Market Share by Region (2015-2020)
Table 11. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Guaifenesin (API) Revenue Share by Region (2015-2020)
Table 13. Global Guaifenesin (API) Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Guaifenesin (API) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Guaifenesin (API) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Guaifenesin (API) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Guaifenesin (API) (MT) of Key Companies (2015-2020)
Table 18. Global Guaifenesin (API) Sales Share by Company (2015-2020)
Table 19. Global Guaifenesin (API) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Guaifenesin (API) Revenue Share by Company (2015-2020)
Table 21. Global Guaifenesin (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guaifenesin (API) as of 2019)
Table 22. Global Guaifenesin (API) Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Guaifenesin (API) Manufacturing Sites and Area Served
Table 24. Manufacturers Guaifenesin (API) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Guaifenesin (API) Players
Table 27. Global Guaifenesin (API) Sales (MT) by Type (2015-2020)
Table 28. Global Guaifenesin (API) Sales Share by Type (2015-2020)
Table 29. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Guaifenesin (API) Price (MT) by Type (2015-2020)
Table 31. Global Guaifenesin (API) Sales Share by Type (2021-2026)
Table 32. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Guaifenesin (API) Revenue Share by Type (2021-2026)
Table 34. Global Guaifenesin (API) Price (MT) by Type (2021-2026)
Table 35. Global Guaifenesin (API) Sales (MT) by Application (2015-2020)
Table 36. Global Guaifenesin (API) Sales Share by Application (2015-2020)
Table 37. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Guaifenesin (API) Price (MT) by Application (2015-2020)
Table 39. Global Guaifenesin (API) Sales (MT) by Application (2021-2026)
Table 40. Global Guaifenesin (API) Sales Share by Application (2021-2026)
Table 41. Global Guaifenesin (API) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Guaifenesin (API) Revenue Share by Application (2021-2026)
Table 43. Global Guaifenesin (API) Price (MT) by Application (2021-2026)
Table 44. United States Guaifenesin (API) Sales (MT) by Company (2015-2020)
Table 45. United States Guaifenesin (API) Sales Market Share by Company (2015-2020)
Table 46. United States Guaifenesin (API) Sales (MT) by Type (2015-2020)
Table 47. United States Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 48. United States Guaifenesin (API) Sales (MT) by Application (2015-2020)
Table 49. United States Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 50. Europe Guaifenesin (API) Sales (MT) by Company (2015-2020)
Table 51. Europe Guaifenesin (API) Sales Market Share by Company (2015-2020)
Table 52. Europe Guaifenesin (API) Sales (MT) by Type (2015-2020)
Table 53. Europe Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 54. Europe Guaifenesin (API) Sales (MT) by Application (2015-2020)
Table 55. Europe Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 56. China Guaifenesin (API) Sales (MT) by Company (2015-2020)
Table 57. China Guaifenesin (API) Sales Market Share by Company (2015-2020)
Table 58. China Guaifenesin (API) Sales (MT) by Type (2015-2020)
Table 59. China Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 60. China Guaifenesin (API) Sales (MT) by Application (2015-2020)
Table 61. China Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 62. Japan Guaifenesin (API) Sales (MT) by Company (2015-2020)
Table 63. Japan Guaifenesin (API) Sales Market Share by Company (2015-2020)
Table 64. Japan Guaifenesin (API) Sales (MT) by Type (2015-2020)
Table 65. Japan Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 66. Japan Guaifenesin (API) Sales (MT) by Application (2015-2020)
Table 67. Japan Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Guaifenesin (API) Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Guaifenesin (API) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Guaifenesin (API) Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Guaifenesin (API) Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 74. India Guaifenesin (API) Sales (MT) by Company (2015-2020)
Table 75. India Guaifenesin (API) Sales Market Share by Company (2015-2020)
Table 76. India Guaifenesin (API) Sales (MT) by Type (2015-2020)
Table 77. India Guaifenesin (API) Sales Market Share by Type (2015-2020)
Table 78. India Guaifenesin (API) Sales (MT) by Application (2015-2020)
Table 79. India Guaifenesin (API) Sales Market Share by Application (2015-2020)
Table 80. Granules Corporation Information
Table 81. Granules Description and Business Overview
Table 82. Granules Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Granules Guaifenesin (API) Product
Table 84. Granules Recent Development
Table 85. Synthokem Labs Corporation Information
Table 86. Synthokem Labs Description and Business Overview
Table 87. Synthokem Labs Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Synthokem Labs Guaifenesin (API) Product
Table 89. Synthokem Labs Recent Development
Table 90. Haizhou Pharma Corporation Information
Table 91. Haizhou Pharma Description and Business Overview
Table 92. Haizhou Pharma Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Haizhou Pharma Guaifenesin (API) Product
Table 94. Haizhou Pharma Recent Development
Table 95. Yuan Cheng Group Corporation Information
Table 96. Yuan Cheng Group Description and Business Overview
Table 97. Yuan Cheng Group Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Yuan Cheng Group Guaifenesin (API) Product
Table 99. Yuan Cheng Group Recent Development
Table 100. Stellar Chemical Corporation Information
Table 101. Stellar Chemical Description and Business Overview
Table 102. Stellar Chemical Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Stellar Chemical Guaifenesin (API) Product
Table 104. Stellar Chemical Recent Development
Table 105. Biesterfeld Corporation Information
Table 106. Biesterfeld Description and Business Overview
Table 107. Biesterfeld Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Biesterfeld Guaifenesin (API) Product
Table 109. Biesterfeld Recent Development
Table 110. Seven Star Pharma Corporation Information
Table 111. Seven Star Pharma Description and Business Overview
Table 112. Seven Star Pharma Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Seven Star Pharma Guaifenesin (API) Product
Table 114. Seven Star Pharma Recent Development
Table 115. Camlin Fine Science Corporation Information
Table 116. Camlin Fine Science Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Camlin Fine Science Description and Business Overview
Table 118. Camlin Fine Science Guaifenesin (API) Product
Table 119. Camlin Fine Science Recent Development
Table 120. Gennex Lab Corporation Information
Table 121. Gennex Lab Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Gennex Lab Description and Business Overview
Table 123. Gennex Lab Guaifenesin (API) Product
Table 124. Gennex Lab Recent Development
Table 125. Iwaki Seiyaku Corporation Information
Table 126. Iwaki Seiyaku Description and Business Overview
Table 127. Iwaki Seiyaku Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Iwaki Seiyaku Guaifenesin (API) Product
Table 129. Iwaki Seiyaku Recent Development
Table 130. Pan Drugs Corporation Information
Table 131. Pan Drugs Description and Business Overview
Table 132. Pan Drugs Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Pan Drugs Guaifenesin (API) Product
Table 134. Pan Drugs Recent Development
Table 135. Delta Synthetic Corporation Information
Table 136. Delta Synthetic Description and Business Overview
Table 137. Delta Synthetic Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. Delta Synthetic Guaifenesin (API) Product
Table 139. Delta Synthetic Recent Development
Table . Smart Pharm Corporation Information
Table . Smart Pharm Description and Business Overview
Table . Smart Pharm Guaifenesin (API) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Smart Pharm Guaifenesin (API) Product
Table . Smart Pharm Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Guaifenesin (API) Distributors List
Table 148. Guaifenesin (API) Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Guaifenesin (API) Product Picture
Figure 2. Global Guaifenesin (API) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Guaifenesin (API) Market Share by Application in 2020 & 2026
Figure 6. Pharmaceuticals Examples
Figure 7. Others Examples
Figure 8. Global Guaifenesin (API) Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Guaifenesin (API) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Guaifenesin (API) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Guaifenesin (API) Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Guaifenesin (API) Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Guaifenesin (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Guaifenesin (API) Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Guaifenesin (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Guaifenesin (API) Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Guaifenesin (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Guaifenesin (API) Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Guaifenesin (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Guaifenesin (API) Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Guaifenesin (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Guaifenesin (API) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Guaifenesin (API) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Guaifenesin (API) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Guaifenesin (API) Players Market Share by Revenue in Guaifenesin (API) 2015 & 2019
Figure 26. Guaifenesin (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Guaifenesin (API) Revenue Share by Type (2015-2020)
Figure 28. Global Guaifenesin (API) Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Guaifenesin (API) Revenue Share by Application (2015-2020)
Figure 30. Global Guaifenesin (API) Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Guaifenesin (API) Sales Market Share by Type in 2019
Figure 32. United States Guaifenesin (API) Sales Market Share by Type in 2019
Figure 33. Europe Guaifenesin (API) Sales Market Share by Company in 2019
Figure 34. Europe Guaifenesin (API) Sales Market Share by Type in 2019
Figure 35. Europe Guaifenesin (API) Sales Market Share by Application in 2019
Figure 36. China Guaifenesin (API) Sales Market Share by Company in 2019
Figure 37. China Guaifenesin (API) Sales Market Share by Type in 2019
Figure 38. China Guaifenesin (API) Sales Market Share by Application in 2019
Figure 39. Japan Guaifenesin (API) Sales Market Share by Company in 2019
Figure 40. Japan Guaifenesin (API) Sales Market Share by Type in 2019
Figure 41. Japan Guaifenesin (API) Sales Market Share by Application in 2019
Figure 42. Southeast Asia Guaifenesin (API) Sales Market Share by Company in 2019
Figure 43. Southeast Asia Guaifenesin (API) Sales Market Share by Type in 2019
Figure 44. Southeast Asia Guaifenesin (API) Sales Market Share by Application in 2019
Figure 45. India Guaifenesin (API) Sales Market Share by Company in 2019
Figure 46. India Guaifenesin (API) Sales Market Share by Type in 2019
Figure 47. India Guaifenesin (API) Sales Market Share by Application in 2019
Figure 48. Granules Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Synthokem Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Haizhou Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Yuan Cheng Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Stellar Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Biesterfeld Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Seven Star Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Camlin Fine Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Gennex Lab Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Iwaki Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Pan Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Delta Synthetic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Smart Pharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Guaifenesin (API)
Figure 63. Manufacturing Process Analysis of Guaifenesin (API)
Figure 64. Guaifenesin (API) Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
ハラール医薬品の世界市場レポート2020 A recently published report by QY Research titled Global Halal Pharmaceuticals Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accur…- カスパーゼ8の世界市場レポート2020 Market Analysis and Insights: Global Caspase 8 Market The global Caspase 8 market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Caspase 8 Scope and Market Size The global Caspase 8 market is segmented by Type,…
- アザシチジンの世界市場レポート2020 Market Analysis and Insights: Global Azacitidine (CAS 320-67-2) Market The global Azacitidine (CAS 320-67-2) market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Azacitidine (CAS 320-67-2) Scope and Market Siz…
- アロセトロンの世界市場レポート2020 Alosetron (original brand name: Lotronex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 …
- オクスカルバゼピン薬の世界市場レポート2020 Oxcarbazepine is an anticonvulsant medication primarily used in the treatment of epilepsy. It may also be used as add-on therapy for bipolar disorder in people that have failed or are unable to tolerate other treatments. Market Analysis and Insights: Global Oxcarbazepine Drug Market The global Oxcar…